Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal testosterone for muscle power in postmenopausal women
ACTRN12623000166673Phase 4Completed
- Sponsor
- Monash University
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Sarcopenia, osteopenia and osteoporosis comparing Testosterone cream with Placebo cream (2 arms). Primary endpoint: Change in body weight-corrected power during two-leg countermovement jump at 26 weeks. Started Jun 2023; status: completed.
02
Drugs
testosterone
03
Conditions
Sarcopeniaosteopeniaosteoporosis
Beyond the preview
Go deeper on ACTRN12623000166673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000166673.